Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies.

D'Acquisto F, May MJ, Ghosh S.

Mol Interv. 2002 Feb;2(1):22-35. Review.

PMID:
14993359
[PubMed - indexed for MEDLINE]
2.
3.

Pathway-specific profiling identifies the NF-kappa B-dependent tumor necrosis factor alpha-regulated genes in epidermal keratinocytes.

Banno T, Gazel A, Blumenberg M.

J Biol Chem. 2005 May 13;280(19):18973-80. Epub 2005 Feb 18.

PMID:
15722350
[PubMed - indexed for MEDLINE]
Free Article
4.

Inhibition of nuclear factor kappa B subunit p65 mRNA accumulation in lipopolysaccharide-stimulated human monocytic cells treated with sodium salicylate.

Takashiba S, Van Dyke TE, Amar S.

Oral Microbiol Immunol. 1996 Dec;11(6):420-4.

PMID:
9467376
[PubMed - indexed for MEDLINE]
5.

Nuclear factor-kappa B.

Barnes PJ.

Int J Biochem Cell Biol. 1997 Jun;29(6):867-70. Review.

PMID:
9304801
[PubMed - indexed for MEDLINE]
6.

Nuclear factor kappa B: important transcription factor and therapeutic target.

Lee JI, Burckart GJ.

J Clin Pharmacol. 1998 Nov;38(11):981-93. Review.

PMID:
9824778
[PubMed - indexed for MEDLINE]
7.

Anti-inflammatory actions of glucocorticoids: molecular mechanisms.

Barnes PJ.

Clin Sci (Lond). 1998 Jun;94(6):557-72. Review.

PMID:
9854452
[PubMed - indexed for MEDLINE]
8.

From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors.

D'Acquisto F, Ianaro A.

Curr Opin Pharmacol. 2006 Aug;6(4):387-92. Epub 2006 Jun 14. Review.

PMID:
16781194
[PubMed - indexed for MEDLINE]
9.

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M.

Science. 1995 Oct 13;270(5234):286-90.

PMID:
7569976
[PubMed - indexed for MEDLINE]
10.

Molecular therapeutic targets in inflammation: cyclooxygenase and NF-kappaB.

Krakauer T.

Curr Drug Targets Inflamm Allergy. 2004 Sep;3(3):317-24. Review.

PMID:
15379601
[PubMed - indexed for MEDLINE]
11.

Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB.

Allen-Hall L, Arnason JT, Cano P, Lafrenie RM.

J Ethnopharmacol. 2010 Feb 17;127(3):685-93. doi: 10.1016/j.jep.2009.12.004. Epub 2009 Dec 6.

PMID:
19995599
[PubMed - indexed for MEDLINE]
12.

A role for transcription factor NF-kappa B in intestinal inflammation.

Schottelius AJ, Baldwin AS Jr.

Int J Colorectal Dis. 1999 Feb;14(1):18-28. Review.

PMID:
10207726
[PubMed - indexed for MEDLINE]
13.

Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models.

Lixuan Z, Jingcheng D, Wenqin Y, Jianhua H, Baojun L, Xiaotao F.

Pulm Pharmacol Ther. 2010 Oct;23(5):411-9. doi: 10.1016/j.pupt.2010.05.004. Epub 2010 May 23.

PMID:
20566376
[PubMed - indexed for MEDLINE]
15.

A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease.

Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, Nadler SG.

J Immunol. 2000 Jul 15;165(2):1004-12.

PMID:
10878377
[PubMed - indexed for MEDLINE]
Free Article
16.

Anti-inflammatory effect of Ishige okamurae ethanolic extract via inhibition of NF-kappaB transcription factor in RAW 264.7 cells.

Kim MM, Rajapakse N, Kim SK.

Phytother Res. 2009 May;23(5):628-34. doi: 10.1002/ptr.2674.

PMID:
19117331
[PubMed - indexed for MEDLINE]
17.

Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression.

Manna SK, Aggarwal BB.

J Immunol. 1999 Feb 15;162(4):2095-102.

PMID:
9973483
[PubMed - indexed for MEDLINE]
Free Article
18.

Activation of nuclear factor kappa B inflammatory bowel disease.

Schreiber S, Nikolaus S, Hampe J.

Gut. 1998 Apr;42(4):477-84.

PMID:
9616307
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.

Catley MC, Sukkar MB, Chung KF, Jaffee B, Liao SM, Coyle AJ, Haddad el-B, Barnes PJ, Newton R.

Mol Pharmacol. 2006 Aug;70(2):697-705. Epub 2006 May 10.

PMID:
16687566
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk